New Jersey Department of Health Issues Update on Lassa Fever Case
TRENTON, N.J. -- No fever or other evidence of infection has been reported to date among individuals who may have had contact with the 38-year-old Trenton man who died on Aug. 28, 2004 of Lassa fever, a virus that is rare in the U.S. but endemic to West Africa. The man returned from a five-month stay in Liberia on Aug. 24, 2004. He flew on Continental Airlines into Newark Liberty International Airport and took a New Jersey Transit train to Trenton.
Officials from the Trenton Health Department and the state Department of Health and Senior Services (DHSS) have been monitoring family members and Capital Health System-Mercer Medical Center has been monitoring the more than 130 healthcare workers who may have come in contact with the patient while hospitalized Aug. 24-28, 2004.
Lassa fever is not easily spread through person-to-person contact. The healthcare workers who were exposed to the patient are considered at low risk.
The Trenton Health Department has also been in contact with the nursing director of the school system attended by children of the patient. As a precaution, the children will not attend school until after Sept. 18, when the incubation period and the risk of disease will have passed.
Source: New Jersey Department of Health
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
